Evidence map›Paper›PMID 32842990›Full record

SynthesisBMC medical genetics2020

Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.

Ali Amar, Ayesha Afzal, Athar Hameed, Mumtaz Ahmad, Abdul Rafay Khan, Humaira Najma, Aiysha Abid, Shagufta Khaliq

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ali AmarDepartment of Human Genetics and Molecular Biology, University of Health Sciences, Khayaban-e-jamia Punjab, Lahore, Punjab, 54600, Pakistan.
Ayesha AfzalDepartment of Human Genetics and Molecular Biology, University of Health Sciences, Khayaban-e-jamia Punjab, Lahore, Punjab, 54600, Pakistan.
Athar HameedDepartment of Urology, Fatima Jinnah Medical University, Lahore, Punjab, Pakistan.
Mumtaz AhmadDepartment of Urology, Fatima Jinnah Medical University, Lahore, Punjab, Pakistan.
Abdul Rafay KhanCentre for Human Genetics and Molecular Medicine, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.
Humaira NajmaDepartment of Human Genetics and Molecular Biology, University of Health Sciences, Khayaban-e-jamia Punjab, Lahore, Punjab, 54600, Pakistan.
Aiysha AbidCentre for Human Genetics and Molecular Medicine, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.
Shagufta KhaliqDepartment of Human Genetics and Molecular Biology, University of Health Sciences, Khayaban-e-jamia Punjab, Lahore, Punjab, 54600, Pakistan. khaliq.shagufta@gmail.com.ORCID 0000-0002-0576-3969
University of Health Sciences Lahore · PKFatima Jinnah Medical University · PKSindh Institute of Urology and Transplantation · PKUniversity of the Punjab · PK

Funding

Higher Education Commision, Pakistan NRPU-1987
6 · The paper itself

Abstract

backgroundUrolithiasis is a worldwide urological problem with significant contribution of genetic factors. Pakistan, which resides within the Afro-Asian stone belt, has a high reported prevalence (12%) of urolithiasis. Osteopontin (SPP1) is a urinary macromolecule with a suggested critical role in modulating renal stone formation, genetic polymorphisms of which may determine individual risk of developing urolithiasis. However, results of previous studies regarding SPP1 polymorphisms and susceptibility to urolithiasis have apparent inconsistencies with no data available for local population.

methodsA total of 235 urolithiasis patients and 243 healthy controls, all of Pakistani ancestry, underwent genotyping for six SPP1 genetic polymorphisms in an effort to investigate potential association with urolithiasis using indigenous candidate gene association study design. Further, a comprehensive meta-analysis following a systematic literature search was also done to ascertain an evidence based account of any existent association regarding SPP1 promoter polymorphisms and risk of developing urolithiasis.

resultsThree SPP1 promoter polymorphisms, rs2853744:G > T, rs11730582:T > C and rs11439060:delG>G, were found to be significantly associated with risk of urolithiasis in indigenous genetic association study (OR = 3.14; p = 0.006, OR = 1.78; p = 0.006 and OR = 1.60; p = 0.012, respectively). We also observed a 1.68-fold positive association of a tri-allelic haplotype of these SPP1 promoter polymorphisms (G-C-dG) with risk of urolithiasis (OR = 1.68; p = 0.0079). However, no association was evident when data were stratified according to gender, age at first presentation, stone recurrence, stone multiplicity, parental consanguinity and family history of urolithiasis. The overall results from meta-analysis, which included 4 studies, suggested a significant association of SPP1 rs2853744:G > T polymorphism with susceptibility of urolithiasis (OR = 1.37; p = 0.004), but not for other SPP1 polymorphic variants analyzed.

conclusionsIn conclusion, we report significant association of 3 SPP1 polymorphisms with urolithiasis for the first time from South Asia, however, this association persisted only for SPP1 rs2853744:G > T polymorphism after meta-analysis of pooled studies. Further studies with a larger sample size will be required to validate this association and assess any potential usefulness in diagnosis and prognosis of renal stone disease.

Indexed as

Polymorphism, Single NucleotideAdolescentAdultAgedAged, 80 and overAllelesCase-Control StudiesChildChild, PreschoolGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMiddle AgedOsteopontinOsteopontinCandidate Gene Association studyMeta-analysisPakistanRenal calculiSNPSPP1

Identifiers

PMID32842990
PMCPMC7446165
OpenAlexW3080526664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.